Home » Topics » Disease categories and therapies » Infection

Infection
RSS

R&D on aminoacyl-tRNA synthetase inhibitors continues at SB; two new compounds identified

May 16, 2000

Therapeutically active bicyclic compounds for herpesvirus infections

May 16, 2000

New lactones with anti-MRSA activity designed at Sankyo

May 15, 2000

SB-219383: a novel bacterial tyrosyl-tRNA synthetase inhibitor produced by Micromonospora

May 12, 2000

Excellent intracellular activity and PAE of ABT-773 against Legionella spp.

May 10, 2000

Voriconazole compares favorably to fluconazole against over 300 Candida isolates

May 10, 2000

Naturally occurring antimicrobial flavanones discovered at RDF

May 10, 2000

Newly issued patent covers novel antifungal series from Aventis

May 10, 2000

HIV-1-derived cationic peptide kills pathogens associated with cystic fibrosis

May 10, 2000

A promising development candidate for RSV disease: ViroPharma's VP-14637

May 9, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...